Loading...

Acquisition Of RED And Growth In Cell Therapy Propel Revenue And Margins In Imaging And Healthcare

Published
17 Dec 24
Updated
05 Sep 25
AnalystConsensusTarget's Fair Value
JP¥1,473.18
23.4% overvalued intrinsic discount
05 Sep
JP¥1,818.00
Loading
1Y
3.3%
7D
4.6%

Author's Valuation

JP¥1.47k23.4% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on05 Sep 25

With both the discount rate and future P/E for Nikon remaining essentially flat, analysts have maintained their consensus price target at ¥1473, signaling a stable view of the company's valuation. What's in the News Nikon lowered full-year earnings guidance, citing the impact of U.S. tariffs and revisions to the first-half outlook.

Shared on01 May 25
Fair value Decreased 6.95%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 1.45%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 8.68%

AnalystConsensusTarget has increased revenue growth from 3.3% to 4.3%, increased profit margin from 5.8% to 7.0% and decreased future PE multiple from 17.1x to 11.7x.